» Authors » P S Rajinikanth

P S Rajinikanth

Explore the profile of P S Rajinikanth including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 144
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Arya D, Pandey P, Kumar A, Chidambaram K, Al Fatease A, Pandey G, et al.
J Liposome Res . 2025 Feb; :1-15. PMID: 39895032
Personalized treatment strategies have greatly improved the efficacy of anticancer drugs. Nanocarriers, especially liposomes, function as excellent platform for the delivery of both hydrophilic and hydrophobic agents. iRGD is a...
2.
Pandey P, Arya D, Kumar A, Kaushik A, Mishra Y, Rajinikanth P
J Mater Chem B . 2025 Jan; 13(8):2682-2694. PMID: 39841132
This research demonstrates the design and development of a novel dual-targeting, pH-sensitive liposomal (pSL) formulation of 5-Fluorouracil (5-FU), , (5-FU-iRGD-FA-pSL) to manage breast cancer (BC). The motivation to explore this...
3.
Shah S, Famta P, Vambhurkar G, Kumar R, Pandey G, Singh G, et al.
Drug Dev Ind Pharm . 2025 Jan; 51(2):132-143. PMID: 39815752
Objective: The objective of the study was to tackle the recurrence of prostate cancer (PCa) post-surgery and to re-sensitize the docetaxel (DTX)-resistant PC-3 cells to chemo-therapy using NIC. Significance: Prolonged...
4.
Pandey P, Chaudhary R, Tripathi D, Lavudi K, Dua K, Weinfeld M, et al.
Med Oncol . 2024 Sep; 41(11):252. PMID: 39320608
Breast cancer (BC) is a leading global concern for women, with 30% being HER2-positive cases linked to poorer outcomes. Targeted therapies like trastuzumab deruxtecan (T-DXd), trastuzumab, pertuzumab, and T-DM1 have...
5.
Chaudhary R, Rehman M, Agarwal V, Kumar A, Kaushik A, Srivastava S, et al.
Life Sci . 2024 Aug; 354:122953. PMID: 39122110
Neuroglial cells, also known as glia, are primarily characterized as auxiliary cells within the central nervous system (CNS). The recent findings have shed light on their significance in numerous physiological...
6.
Kanaujiya S, Arya D, Pandey P, Singh S, Pandey G, Anjum S, et al.
Int J Nanomedicine . 2024 Jun; 19:5397-5418. PMID: 38863647
Background: The healing of burn wounds is a complicated physiological process that involves several stages, including haemostasis, inflammation, proliferation, and remodelling to rebuild the skin and subcutaneous tissue integrity. Recent...
7.
Anjum S, Wang Y, Xin Y, Li X, Li T, Zhang H, et al.
Mater Today Bio . 2024 May; 26:101088. PMID: 38779556
Osteogenic-osteoclast coupling processes play a crucial role in bone regeneration. Recently, strategies that focus on multi-functionalized implant surfaces to enhance the healing of bone defects through the synergistic regulation of...
8.
Nanda A, Pandey P, Rajinikanth P, Singh N
Int J Biol Macromol . 2024 Jan; 260(Pt 1):129416. PMID: 38224810
Zein, a protein-based biopolymer derived from corn, has garnered attention as a promising and eco-friendly choice for packaging food due to its favorable physical attributes. The introduction of electrospinning technology...
9.
Deepak P, Kumar P, Pandey P, Arya D, Jaiswal S, Kumar A, et al.
Int J Nanomedicine . 2023 Dec; 18:7021-7046. PMID: 38046236
Background: Antitumor research aims to efficiently target hepatocarcinoma cells (HCC) for drug delivery. Nanostructured lipid carriers (NLCs) are promising for active tumour targeting. Cell-penetrating peptides are feasible ligands for targeted...
10.
Pandey G, Phatale V, Khairnar P, Kolipaka T, Shah S, Famta P, et al.
Int J Biol Macromol . 2023 Dec; 256(Pt 2):128452. PMID: 38042321
Cancer is a devastating disease that causes a substantial number of deaths worldwide. Current therapeutic interventions for cancer include chemotherapy, radiation therapy, or surgery. These conventional therapeutic approaches are associated...